WHAT IS DEMENTIA?

Dementia is a general term for a steady decline in mental ability. It is caused when the brain is damaged by diseases or a series of strokes. Alzheimer’s is the most common manifestation, totaling almost 70% of Dementia cases. It is the most common cause of disability among the aged.
Today, there are around 50 million dementia patients across the globe. This condition impairs a person’s ability to think, remember and reason. Also, its impact on family and social environments is severe, causing stress and hardship for both patients and caregivers.
Dementia patients need personalized treatment, which means that each individual case has different parameters that have to be analyzed and addressed separately. Meditourz has given patients access to top-notch specialists who have provided timely and effective treatment.

WHAT ARE THE SYMPTOMS OF DEMENTIA?

The most common symptoms are:

  • Memory loss
  • Difficulty with reasoning and logic
  • Problems with language
  • Difficulty with thinking
  • Lack of motivation
  • Erratic mood swings

HOW WILL AUTOLOGOUS STEM CELL THERAPY HELP DEMENTIA PATIENTS?

Autologous Stem Cell Treatment for Dementia has the potential to help Dementia patients in many ways:

  • Stem cells can slow down deterioration.
  • They can help repair and restore damaged brain tissue.
  • Specific areas can be targeted.
  • Creation of new nerve cells can be triggered.
  • Other metabolic activities can also be improved.

Following Autologous Stem Cell Therapy, the progression of dementia is slowed significantly and patients show marked improvement in cognitive functions and independence.
By facilitating the connect between doctors and dementia patients, we at Meditourz strive to improve the quality of life for a dementia patient, making the condition more manageable and ensuring that they are able to live a meaningful and fulfilling life.

 

DR ALOK SHARMAMBBS, M.S., M.CH



Dr Alok Sharma is a world-renowned Neurosurgeon, Neuroscientist and Professor with decades of surgical expertise in Neurosurgery, Neuroscience and Autologous Stem Cell Therapy. In 1995, he worked at the Karolinska Hospital in Stockholm, Sweden, where neural transplantation was performed for the first time in the world. He has also worked at the University of Colorado's Health Sciences Center in Denver, USA, where the world's first randomized trial for cell transplantation was done for Parkinson's disease. Dr Alok has authored many books, published over 100 scientific publications and contributed over 150 scientific presentations at international, national and zonal conferences.